• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Quality of life, treatment goals, preferences and satisfaction in older adults with psoriasis: a patient survey comparing age groups.老年银屑病患者的生活质量、治疗目标、偏好及满意度：一项比较年龄组的患者调查
Br J Dermatol. 2021 Apr;184(4):759-762. doi: 10.1111/bjd.19665. Epub 2020 Dec 30.
2
Treatment satisfaction and quality of life in patients with psoriasis may not be directly associated. Preliminary study.
Cir Cir. 2021;89(6):846-847. doi: 10.24875/CIRU.20000606.
3
Ixekizumab in the treatment of moderate-to-severe plaque psoriasis: Patient adherence, satisfaction, and preferences.依奇珠单抗治疗中重度斑块型银屑病：患者的依从性、满意度和偏好。
Dermatol Ther. 2021 Jan;34(1):e14486. doi: 10.1111/dth.14486. Epub 2020 Nov 10.
4
Patient-relevant needs and treatment goals in nail psoriasis.甲银屑病中与患者相关的需求和治疗目标
Qual Life Res. 2016 May;25(5):1179-88. doi: 10.1007/s11136-015-1136-y. Epub 2015 Oct 3.
5
Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment.比较英国患者和皮肤科医生对银屑病治疗结果的偏好：一项离散选择实验的结果。
Br J Dermatol. 2017 Mar;176(3):777-785. doi: 10.1111/bjd.14798. Epub 2016 Sep 24.
6
Treatment goals in psoriasis from a patient perspective: a qualitative study.从患者角度看银屑病的治疗目标：一项定性研究。
J Dermatolog Treat. 2020 Feb;31(1):13-17. doi: 10.1080/09546634.2018.1544408. Epub 2019 Jul 12.
7
Patient-relevant treatment goals in psoriasis.银屑病中与患者相关的治疗目标。
Arch Dermatol Res. 2016 Mar;308(2):69-78. doi: 10.1007/s00403-015-1613-8. Epub 2015 Dec 19.
8
Treatment patterns, treatment satisfaction, severity of disease problems, and quality of life in patients with psoriasis in three Nordic countries.在三个北欧国家中，银屑病患者的治疗模式、治疗满意度、疾病问题的严重程度和生活质量。
Acta Derm Venereol. 2013 Jul 6;93(4):442-5. doi: 10.2340/00015555-1485.
9
Quality of life, treatment satisfaction and efficacy of non-biological systemic therapies in patients with plaque psoriasis: study protocol for a prospective observational study.斑块状银屑病患者非生物系统性疗法的生活质量、治疗满意度及疗效：一项前瞻性观察性研究的研究方案
BMJ Open. 2017 Jun 30;7(6):e014279. doi: 10.1136/bmjopen-2016-014279.
10
Assessment of medication adherence and treatment satisfaction in Japanese patients with psoriasis of various severities.评估不同严重程度银屑病日本患者的药物依从性和治疗满意度。
J Dermatol. 2018 Jun;45(6):727-731. doi: 10.1111/1346-8138.14225. Epub 2018 Jan 21.

引用本文的文献

1
Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and reSURFACE 2) Through 244 Weeks.替西罗莫司在老年患者中的疗效和安全性：两项随机 III 期临床试验（reSURFACE 1 和 reSURFACE 2）的 244 周汇总分析。
Acta Derm Venereol. 2023 Oct 25;103:adv17752. doi: 10.2340/actadv.v103.17752.
2
Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study.司库奇尤单抗治疗中重度斑块型银屑病老年患者的疗效和安全性：SUPREME研究的事后分析
Clin Cosmet Investig Dermatol. 2023 Apr 1;16:847-852. doi: 10.2147/CCID.S400520. eCollection 2023.
3
Safety Assessment of Conventional and Biological Systemic Therapy in Older Adults with Psoriasis, a Real-world Multicentre Cohort Study.老年人银屑病常规和生物系统治疗的安全性评估：一项真实世界多中心队列研究。
Acta Derm Venereol. 2022 Oct 31;102:adv00805. doi: 10.2340/actadv.v102.2412.
4
Drug Survival, Safety, and Effectiveness of Biologics in Older Patients with Psoriasis: A Comparison with Younger Patients-A BioCAPTURE Registry Study.生物制剂在老年银屑病患者中的生存、安全性和有效性：与年轻患者的比较——一项 BioCAPTURE 登记研究。
Drugs Aging. 2022 Sep;39(9):715-727. doi: 10.1007/s40266-022-00961-y. Epub 2022 Jul 21.
5
A Rasch model analysis of two interpretations of 'not relevant' responses on the Dermatology Life Quality Index (DLQI).基于德克萨斯州皮肤研究所（TDLR）评分标准，评估两种不同的“不相关”反应对皮肤病生活质量指数（DLQI）的影响。
Qual Life Res. 2021 Aug;30(8):2375-2386. doi: 10.1007/s11136-021-02803-7. Epub 2021 Mar 8.

本文引用的文献

1
Effectiveness and Safety of Systemic Therapy for Psoriasis in Older Adults: A Systematic Review.老年人银屑病系统治疗的有效性和安全性：系统评价。
JAMA Dermatol. 2020 Nov 1;156(11):1229-1239. doi: 10.1001/jamadermatol.2020.2311.
2
Disease and Treatment Characteristics in Geriatric Psoriasis: A Patient Survey Comparing Age Groups.老年银屑病的疾病与治疗特征：一项比较年龄组的患者调查
Acta Derm Venereol. 2020 Jul 28;100(14):adv00215. doi: 10.2340/00015555-3569.
3
Assessment of Attitudes Toward Deprescribing in Older Medicare Beneficiaries in the United States.评估美国老年医疗保险受益人群对药物减量的态度。
JAMA Intern Med. 2018 Dec 1;178(12):1673-1680. doi: 10.1001/jamainternmed.2018.4720.
4
Proposal of a new scoring formula for the Dermatology Life Quality Index in psoriasis.提出一种新的银屑病皮肤病生活质量指数评分公式。
Br J Dermatol. 2018 Nov;179(5):1102-1108. doi: 10.1111/bjd.16927. Epub 2018 Sep 19.
5
A detailed analysis of 'not relevant' responses on the DLQI in psoriasis: potential biases in treatment decisions.对银屑病 DLQI 中“不相关”回答的详细分析：治疗决策中的潜在偏差。
J Eur Acad Dermatol Venereol. 2018 May;32(5):783-790. doi: 10.1111/jdv.14676. Epub 2017 Nov 28.
6
The impact of age on psoriasis health care in Germany.年龄对德国银屑病医疗保健的影响。
J Eur Acad Dermatol Venereol. 2017 May;31(5):870-875. doi: 10.1111/jdv.14115. Epub 2017 Mar 9.
7
Evaluating equality in psoriasis healthcare: a cohort study of the impact of age on prescription of biologics.评估银屑病医疗保健中的平等性：一项队列研究，探讨年龄对生物制剂处方的影响。
Br J Dermatol. 2016 Mar;174(3):579-87. doi: 10.1111/bjd.14331. Epub 2016 Feb 4.
8
Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry.经典和生物系统性疗法治疗老年银屑病的安全性：一项来自国家BIOBADADERM注册研究的观察性研究
J Eur Acad Dermatol Venereol. 2015 May;29(5):858-64. doi: 10.1111/jdv.12688. Epub 2014 Sep 3.

Quality of life, treatment goals, preferences and satisfaction in older adults with psoriasis: a patient survey comparing age groups.

作者信息

van Winden M E C, Ter Haar E L M, Groenewoud J M M, van de Kerkhof P C M, de Jong E M G J, Lubeek S F K

机构信息

Department of Dermatology, Radboud University Medical Centre, Radboud Institute for Health Sciences, Nijmegen, the Netherlands.

Department for Health Evidence, Radboud University, Nijmegen, the Netherlands.

出版信息

Br J Dermatol. 2021 Apr;184(4):759-762. doi: 10.1111/bjd.19665. Epub 2020 Dec 30.

DOI:10.1111/bjd.19665
PMID:33152111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8246713/
Abstract
摘要